| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $57.7M | -31.8% |
| Cost of Revenue | $20.9M | -21.7% |
| R&D Expense | $56.6M | -46.6% |
| SG&A Expense | $87.7M | -6.8% |
| Operating Income | -$110.4M | +22.5% |
| Interest Expense | $13.5M | -11.7% |
| Pre-tax Income | -$120.5M | +21.5% |
| Income Tax | $312K | -40.1% |
| Net Income | -$46.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $57.3M | -29.2% |
| Accounts Receivable | $10.2M | -32.8% |
| Inventory | $14.4M | +41.4% |
| Current Assets | $90.4M | -22.8% |
| Total Assets | $144.2M | -13.9% |
| Current Liabilities | $71.4M | -15.9% |
| Long-term Debt | $58.0M | -4.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$80.2M | +37.5% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | -$15.0M | -613.3% |
| Financing Cash Flow | $70.6M | +115.8% |
| Free Cash Flow | -$80.2M | +37.5% |
| +24.1% |
| EPS (Basic) | -$2.69 | +68.2% |
| EPS (Diluted) | -$2.69 | +68.2% |
| Total Liabilities |
| $145.9M |
| -12.1% |
| Stockholders' Equity | $22.7M | +0.9% |